ADAMTS13 and hemolytic-uremic syndrome: In the suspicion of a congenital form of HUS, the ADAMTS13 level should be evaluated by measuring both its activity with a fluorogenic assay [39] and its antigen level to differentiate between type 1 (both activity and antigen decreased) and type 2 deficiency (severe activity defect associated with subnormal antigen level).